The BHF is keen to explore working with partners in the commercial sector in order to support research and innovation, as we work towards our vision of a world free from the fear of heart and circulatory diseases.
It’s a bold ambition, and we can’t achieve it alone. But by working with others towards game-changing research-driven milestones we believe great progress can be made.
The BHF approach to partnering with those in the commercial sector is built upon the Association of Medical Research Charities (AMRC) core principles for collaborative working - Integrity, Independence and Transparency - and on the guidance published in March 2019 by the Charity Commission on how charities should connect with non-charities.
Integrity - All partners must be aligned with the values of the BHF: brave, informed, compassionate and driven. We will always act with honesty and integrity in all that we do.
Independence - The BHF will ensure that it maintains independence of its decision making in all partnerships. We are an independent voice for those affected by heart and circulatory diseases in the UK and will always remain so.
Transparency - All partnerships must be transparent. We will be clear on which organisations we are working with and why. Details of these partnerships will be published on our website throughout their duration.
All BHF partnerships must conform to Charity Commission guidelines and the codes of practice of the Association of Medical Research Charities (AMRC) and other relevant trade bodies for the Charity sector.
Partner organisations will also be expected to comply with the requirements of umbrella or trade bodies, depending on the activities of the partner organisation.
For the healthcare industry these bodies include the Association of the British Pharmaceutical Industry (ABPI), Association of British Healthcare Industries (ABHI) and the UK BioIndustry Association (BIA).